Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30

Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30

$4.85−0.55 (-10.19%)

Close on Nov 13, 2026Market cap $39.10MP/E –Yield –

Cryo-Cell International price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Cryo-Cell International's price to book ratio was 11.6× on Sep 30, 2022, against 25.5× a year earlier.

Period	Period end	Value	Change (pts)
2022	Sep 30, 2022	11.6×	−9.0
2021	Dec 31, 2021	20.6×	–

Parsed from the XBRL in Cryo-Cell International's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CCEL.

Revenue growth-2.0% · median -17.8%

Gross margin78.5% · median 22.1%

Operating margin0.6% · median -78.4%

Net margin-6.2% · median -98.0%

Advertisement
300 × 250

See a number that looks wrong?